Novo CEO pressed by Senate to chop costs of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would contemplate new talks with insurers in regards to the listing prices of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Given that some https://buschlightpeachcalories30629.ziblogs.com/30720391/not-known-factual-statements-about-healthcare-news